AstraZeneca has become the latest big pharma company to devote new cash to its US manufacturing muscle this year as it ...
The chart below compares the forward price to earnings (P/E) ratio of AstraZeneca to multiples in a peer set of leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback